Under the category of the OTC/Nutraceutical products are listed the products which are sold without prescription. Members of Farmavita.net are invited to publish their out-license offers in this Category.

Levofloxacin hemihydrate

Popular

Description

There is on-going development of generic EU CTD Dossier of Levofloxacin hemihydrate, 250/500 mg, filmcoated tablets. 

Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.

Levofloxacin is a synthetic chemotherapeutic agent used to treat severe or life threatening bacterial infections. It is sold under various brand names, such as Levaquin and Tavanic, the most common. In form of ophthalmic solutions it is known as Oftaquix, Quixin and Iquix. Levofloxacin belongs to the class of fluoroquinolone (or quinolone) antiinfectives.

Chemically, levofloxacin is a chiral fluorinated carboxyquinolone. Investigation of ofloxacin, an older drug that is the racemic mixture, found that the l form [the (-)-(S) enantiomer] is more active. This specific component is levofloxacin.

Levofloxacin interacts with a number of other drugs, as well as a number of herbal and natural supplements. Such interactions increase the risk of cardiotoxicity and arrhythmias, anticoagulation, the formation of non-absorbable complexes, as well as increasing the risk of toxicity.

More details at: http://www.rxlist.com/levaquin-drug.htm

More details

Name Description
Pharma licensing Out-licensing (offer)

Ad details

Ad ID : 585

Advertiser details

Contact Advertiser

Add comment

 
 

Contact form

Sorry, you need to register or login first.

What's wrong with this ad?

Sorry, you need to register or login first.

Add to favourites

Sorry, you need to register or login first.

Advert search

Recent adverts

I want to give process knowhow and NON GMO...
n/a
617 Views
OUT-LICENSING HYBRID DOSSIER OF ALIMEMAZINE...
733 Views
 Company portfolio: Manufacturing over 100...
1164 Views
Objective: To enter into EU domain procuring...
903 Views
Objective: To enter into EU domain grabbing a...
751 Views
OUT-LICENSING DOSSIER OF ALIMEMAZINE TABLETS OF...
708 Views
Please contact me.  if you need...
1292 Views